MS News That Caught My Eye Last Week: COVID-19 Vaccines, Benign and Aggressive MS, Cog Fog, Diet
All of the stories this week are from the ACTRIMS 2021 Forum, an MS research conference held virtually Feb. 25–27.
Articles by Ed Tobias
I Had a Stupid, Scary Spill, but It Could Have Been Much Worse
“Ooooops!” Actually, I spit out a shorter, one-syllable word as I took one of the scariest tumbles I’ve had in…
MS News That Caught My Eye Last Week: POMS and Sunshine, Music Therapy, Tysabri, Socioeconomic Status
Stories marked #ACTRIMS2021 are by members of the Multiple Sclerosis News Today team, who reported on this annual conference of…
The Disturbing Trend of Caregiver Abuse in the MS Community
This is disturbing and, unfortunately, not surprising. More than 50% of people with advanced multiple sclerosis reported they’ve been mistreated…
MS News That Caught My Eye Last Week: Tysabri, Evobrutinib, Diet Study, Rituximab
Drop in PML With Tysabri Use in Sweden Likely Due to Risk Management Plan I’m JCV-positive, so I’m at…
Are You Having Trouble Paying for Your MS Medications?
If you’re having trouble paying for your MS medications, you’re not alone. I regularly see social media posts from people…
MS News That Caught My Eye Last Week: DMTs and COVID-19 Vaccines, Better Trials, Ocrevus, Spinal Lesions
National MS Society Urges DMT Dosing Changes for COVID-19 Vaccinations The National MS Society has revised its COVID-19 vaccine…
The First COVID-19 Shot Is Finally in My Arm
It’s a good thing my wife, Laura, is persistent. Thanks to her tenacity, we’ve both been able to get our…
MS News That Caught My Eye Last Week: Plegridy, Telemedicine, AI for MS, Myelin Repair
FDA Approves Plegridy as Intramuscular Injection for Relapsing MS A common patient complaint about Plegridy has been that its…
Upper Body Health Also Is Important for People With MS
My left hand was numb and weak when I was first diagnosed with multiple sclerosis. For years after that, symptoms…
MS News That Caught My Eye Last Week: Pediatric MS, Rituximab, AHSCT, Zeposia
Tecfidera Safe and Effective Over Long Term in Children With RRMS, Trial Shows In my view, too little attention…
Don’t Jump to Conclusions Over a Breakthrough MS Vaccine Just Yet
A medical website’s headline screamed, “Breakthrough Multiple Sclerosis Vaccine Shows Impressive Results In Study.” The New York Daily News…
MS News That Caught My Eye Last Week: Nanocrystals, ‘Cog Fog,’ Mapping MS, Ocrevus
Clene Awaits US Patent Covering Gold Nanocrystals’ Use in Treating MS This is a different approach to MS treatment.
Car Repairs Aren’t Easy When You Have MS
I love the car I drive, but I’ve hated going to the dealer to get my car serviced. In the…
MS News That Caught My Eye Last Week: CBD, Sativex, Lemtrada, Sexual Dysfunction
Public-private Partnership Will Assess Therapy Potential, Effects of CBD Have you tried using CBD to treat your MS? I…
COVID-19 Vaccine Gets Thumbs-up from National MS Society
The advice issued Tuesday by the U.S.-based National Multiple Sclerosis Society about COVID-19 vaccination couldn’t be clearer: “Get your vaccine…
MS News That Caught My Eye Last Week: DMTs and Disease Progression, Obesity, Sunlight and Relapses, MS Fatigue
Study: Past Long-term DMT Use Tapers Risk of Current MS Progression Since being diagnosed in 1980, I’ve used four…
Can Amazon Lower Healthcare Costs?
The answer to whether Amazon, in partnership with a pair of financial giants, can make healthcare more accessible and less…
Will Reduced Treatment Time Keep Ocrevus Competitive?
One of the key considerations when choosing a disease-modifying therapy (DMT) is how much it will disrupt your life. It’s…
MS News That Caught My Eye Last Week: Stem Cell Study, Protein Predictor, Tolebrutinib and STEP Trials
Stem Cell Therapy Shows 2-year Benefit for Progressive MS Patients in Phase 1 Trial Stem cell studies always catch…
Getting Back to Physical Therapy for My MS
Are you sitting down? I am, but I’ve been doing too much of that this year. For the past six…
MS News That Caught My Eye Last Week: Fatigue Trial, Pediatric MS Relapses, Stem Cell Transplant
MS Patients Urged to Enroll in Clinical Trial Assessing Chronic Fatigue Treatments My “MS Wire” column 10 days…
Can I Get a COVID-19 Vaccine If I Have MS?
Do you plan to get a COVID-19 vaccine? I do. One is now available to some residents of the U.K.,…
MS News That Caught My Eye Last Week: Quality of Life, Virtual Reality Rehab, Aubagio and Brain Atrophy, Cancer Risk
Review Study Examines Factors That Affect MS Patients’ Quality of Life What affects the qualify of your life as…
There Is No Magic Pill for MS Fatigue
I’ve been tired all day, which is nothing new, as fatigue and multiple sclerosis go hand in hand. It’s been…
MS News That Caught My Eye Last Week: More Tysabri Benefits, Long-term Ocrevus Data, Trial Diversity, MS and the Gut
Tysabri Affects Immune System Beyond Known MS Target, Study Finds Tysabri (natalizumab) slows multiple sclerosis progression by blocking some…
MS News That Caught My Eye Last Week: Typing Patterns and MS Progression, Cognitive Testing, Multitasking, Autoimmune Registry
Smartphone Typing Patterns May Be Tool for Monitoring MS Progression, Study Finds This is an interesting concept that makes…
Travel During COVID-19: Should We Stay or Should We Go?
The temperature’s dropping. The wind is whipping. It’s time for my wife, Laura, and me to head south, leaving cold,…
MS News That Caught My Eye Last Week: Possible MS Blood Test, IMU-838, aHSCT vs. Lemtrada
Neurofilament Light Levels at First MS Event Can Predict Long-term Brain Atrophy Researchers are looking at a protein that’s…
MSIF Issues New Recommendations to Protect Against COVID-19
The Multiple Sclerosis International Federation (MSIF) has issued new recommendations about how people with MS should adjust their daily…